Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon. It is characterized by the presence of malignant small cells.
Biomarker and diagnostic research for colon small cell neuroendocrine carcinoma has been reported in the published literature.
No clinical trials have been registered for colon small cell neuroendocrine carcinoma.
131 publications have been identified in PubMed for colon small cell neuroendocrine carcinoma. Research spans Case Report / Case Series (30%), Basic Science / Preclinical (27%), and Gene Therapy / Novel Therapeutics (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 39 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Common questions about colon small cell neuroendocrine carcinoma
Laboratory research
36 |
27% |
New treatment approaches | 21 | 16% |
Testing and diagnosis research | 11 | 8% |
Disease patterns and progression | 10 | 8% |
Research summaries | 8 | 6% |
Clinical study results | 5 | 4% |
Other research | 1 | 1% |
Michael A (2026). [PMID: 41963596](https://pubmed.ncbi.nlm.nih.gov/41963596/). *Br J Cancer*. [Other]
Lonnes R (2026). [PMID: 41871600](https://pubmed.ncbi.nlm.nih.gov/41871600/). *Zentralbl Chir*. [Case Report / Case Series]
Mansour NI (2026). [PMID: 41418598](https://pubmed.ncbi.nlm.nih.gov/41418598/). *Bioorg Chem*. [Gene Therapy / Novel Therapeutics]
Habermann EB (2026). [PMID: 41562441](https://pubmed.ncbi.nlm.nih.gov/41562441/). *J Am Coll Surg*. [Case Report / Case Series]
Kashiwagi J (2026). [PMID: 41969301](https://pubmed.ncbi.nlm.nih.gov/41969301/). *Surg Case Rep*. [Case Report / Case Series]
Matias A (2026). [PMID: 41908506](https://pubmed.ncbi.nlm.nih.gov/41908506/). *ACG Case Rep J*. [Case Report / Case Series]
Jiang W (2026). [PMID: 41782949](https://pubmed.ncbi.nlm.nih.gov/41782949/). *Clinical case reports*. [Basic Science / Preclinical]
Conner MC (2026). [PMID: 42186647](https://pubmed.ncbi.nlm.nih.gov/42186647/). *Cureus*. [Case Report / Case Series]
Peng H (2026). [PMID: 41720764](https://pubmed.ncbi.nlm.nih.gov/41720764/). *Cell death & disease*. [Basic Science / Preclinical]
Thomas S (2026). [PMID: 41717188](https://pubmed.ncbi.nlm.nih.gov/41717188/). *Cureus*. [Clinical Trial Publication]
AI-curated news mentioning colon small cell neuroendocrine carcinoma
Updated May 10, 2026
A recent study highlights adolescent-onset primary small cell neuroendocrine carcinoma of the nasal cavity as a rare and aggressive cancer, yet with a favorable outcome. This research contributes to the understanding of this uncommon disease and its clinical implications.
A recent study details the clinicopathological and molecular genetic characteristics of Epstein-Barr virus-positive small cell neuroendocrine carcinoma of the nasopharynx. This research enhances understanding of the disease's genetic profile and potential therapeutic targets.